Adoptive T-cell Therapy for Resistant Viral Infections After Allogeneic HSCT
Condition(s):Viral Infection After HSCTLast Updated:March 6, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Viral Infection After HSCTLast Updated:March 6, 2024Not yet recruiting
Condition(s):Adenovirus Infection; BK Virus Infection; Cytomegaloviral Infection; Hematopoietic and Lymphoid Cell Neoplasm; JC Virus Infection; Malignant Solid Neoplasm; Symptomatic COVID-19 Infection Laboratory-ConfirmedLast Updated:October 16, 2023Recruiting
Condition(s):VirusesLast Updated:November 10, 2020Completed
Condition(s):Heart; Surgery, Heart, Functional Disturbance as ResultLast Updated:May 16, 2023Completed
Condition(s):Respiratory Viral InfectionLast Updated:August 30, 2023Recruiting
Condition(s):Simian Foamy Virus Infection (Disorder)Last Updated:August 17, 2022Recruiting
Condition(s):Infection in Solid Organ Transplant Recipients; Complications of Organ Transplant; Respiratory Viral InfectionLast Updated:December 16, 2015Completed
Condition(s):Viral Infections; Bone Marrow Transplant InfectionLast Updated:September 21, 2023Active, not recruiting
Condition(s):Bacterial Infections; Viral InfectionLast Updated:March 8, 2019Unknown status
Condition(s):ZIKA VIRUS INFECTION; Child Development; MicrocephalyLast Updated:May 3, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.